RE: MedImmune20 Dec 2018 09:21
"The Company has subsequently licensed back to UNIQUEST certain defined fields which the Company does not consider relevant to the Company's targeted applications, but in which UNIQUEST is intending to carry out research"
The above reads, in my opinion, that there are many avenues being explored, possibly Medimmune is testing the targeted applications?